Favorable Press Coverage Somewhat Unlikely to Affect Achieve Life Sciences (ACHV) Share Price
Media headlines about Achieve Life Sciences (NASDAQ:ACHV) have trended positive on Wednesday, Accern Sentiment Analysis reports. Accern scores the sentiment of media coverage by monitoring more than 20 million blog and news sources in real-time. Accern ranks coverage of companies on a scale of negative one to positive one, with scores closest to one being the most favorable. Achieve Life Sciences earned a coverage optimism score of 0.36 on Accern’s scale. Accern also gave headlines about the biopharmaceutical company an impact score of 44.8019957983193 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the company’s share price in the near term.
Separately, ValuEngine raised shares of Achieve Life Sciences from a “strong sell” rating to a “sell” rating in a research note on Monday, December 4th.
Shares of Achieve Life Sciences (NASDAQ ACHV) remained flat at $$1.40 during trading hours on Wednesday. The company’s stock had a trading volume of 55,000 shares, compared to its average volume of 507,306. Achieve Life Sciences has a fifty-two week low of $1.15 and a fifty-two week high of $7.15. The firm has a market capitalization of $16.73, a PE ratio of -0.26 and a beta of 2.01.
COPYRIGHT VIOLATION WARNING: This piece was reported by The Cerbat Gem and is owned by of The Cerbat Gem. If you are viewing this piece on another publication, it was illegally stolen and republished in violation of U.S. and international copyright & trademark laws. The legal version of this piece can be read at https://www.thecerbatgem.com/2018/02/14/favorable-press-coverage-somewhat-unlikely-to-affect-achieve-life-sciences-achv-share-price.html.
Achieve Life Sciences, Inc, formerly OncoGenex Pharmaceuticals, Inc, is a clinical-stage pharmaceutical company engaged in the development and commercialization of therapies that address treatment resistance in cancer patients. The Company’s segment is dedicated to the development and commercialization of cancer therapies, with operations located in Canada and the United States.
Receive News & Ratings for Achieve Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Achieve Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.